It has been reported that c-MPL is highly expressed in LSCs of AML and high level of TPO/c-MPL signaling in AML enhances cell resistance to chemotherapy, survival and self-renewing capacity [32, 34, 35, 51–53]. This evidence concerns the gene TPO and acute myeloid leukemia.